Chan Gerald 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 3, 2019
Insider Transaction Report
Form 4
Chan Gerald
Director
Transactions
- Award
Stock option (right to buy)
2019-01-01+17,580→ 17,580 totalExercise: $13.19Exp: 2028-12-31→ Common Stock (17,580 underlying)
Footnotes (1)
- [F1]This option was granted on January 1, 2019 and will vest in four equal quarterly installments on April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020, subject to continued service as a director.